Drug therapy for cardiac arrhythmias.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001285:Atropine / Q000009:adverse effects / Q000627:therapeutic use; D001949:Bretylium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000627:therapeutic use; D004837:Epinephrine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007545:Isoproterenol / Q000009:adverse effects / Q000627:therapeutic use; D008012:Lidocaine / Q000009:adverse effects / Q000627:therapeutic use; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use; D011188:Potassium / Q000009:adverse effects / Q000627:therapeutic use; D011342:Procainamide / Q000009:adverse effects / Q000627:therapeutic use; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D011802:Quinidine / Q000009:adverse effects / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D004071:Digitalis Glycosides; D010672:Phenytoin; D001285:Atropine; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D007545:Isoproterenol; D011188:Potassium; D004837:Epinephrine